SSJ-183

CCN(CC)C1=CC2=C(C=C1)N=C3C(O2)=CC(=NC4=CC=NC=C4)C5=C3C=CC=C5

InChIKey=HBSWMATYASLRBW-UHFFFAOYSA-N

InChI=1S/C25H22N4O/c1-3-29(4-2)18-9-10-21-23(15-18)30-24-16-22(27-17-11-13-26-14-12-17)19-7-5-6-8-20(19)25(24)28-21/h5-16H,3-4H2,1-2H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

PubMed

Title	Date	PubMed
In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.	2013	24255594

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:23:11 GMT 2025` Edited by `admin` on `Mon Mar 31 21:23:11 GMT 2025`
Record UNII	2EJ2TIK905
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

9-N,N-DIETHYLAMINO-5-(PYRIDIN-4-YLIMINO)-5H-BENZO(A)PHENOXAZINE

Preferred Name

English

SSJ-183

Common Name

English

5H-BENZO(A)PHENOXAZIN-9-AMINE, N,N-DIETHYL-5-(4-PYRIDINYLIMINO)-

Systematic Name

English

Code System Code Type Description

CAS

1187533-34-1

Created by admin on Mon Mar 31 21:23:11 GMT 2025 , Edited by admin on Mon Mar 31 21:23:11 GMT 2025

PRIMARY

FDA UNII

2EJ2TIK905

Created by admin on Mon Mar 31 21:23:11 GMT 2025 , Edited by admin on Mon Mar 31 21:23:11 GMT 2025

PRIMARY

PUBCHEM

44226912

Created by admin on Mon Mar 31 21:23:11 GMT 2025 , Edited by admin on Mon Mar 31 21:23:11 GMT 2025

PRIMARY